FindMyRecallSubscribe
Class I: serious health riskTerminated

Sanofi-Aventis U.S. Auvi-Q Recall

Auvi-Q (epinephrine injection, USP) Auto-Injector, 0

Sanofi-Aventis U.S. LLC · Bridgewater, NJ

Risk level
Class I
Reported by FDA
Jun 1, 2016
Recall ID
D-0873-2016
Check your lot numberHow we source this data

Summary

Sanofi-Aventis U.S. recalled Auvi-Q starting Oct 28, 2015. The FDA classified it as Class I (serious health risk) and published enforcement report D-0873-2016 on Jun 1, 2016. Reason: Defective Delivery System; potential to have inaccurate dosage delivery. Status: Terminated.

Why it was recalled

Defective Delivery System; potential to have inaccurate dosage delivery

Product description

Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.15 mg (a) 2 prefilled auto injectors + 1 trainer (NDC 0024-5831-02) and (b) 1 prefilled auto injector + 1 trainer (NDC 0024-5831-00), Rx Only, Manufactured for Sanofi-Aventis US, LLC Bridgewater, NJ 08807 A Sanofi Company

Lot numbers, UPCs & expiration codes

a) 2144144, exp 10/2015; 2469674, exp 04/2016; 2506492, 2546978, 2546979, exp 05/2016; 2654817, 2654818, exp 06/2016; 2692143, 2692144, exp 07/2016; 2719838, exp 08/2016; 2824845, 2891021, 2857530, exp 09/2016; 2883631, 2883632, exp 10/2016; 2883633, 2945429, 3028243, exp 11/2016; 3037230, 2966680, 2974276, 2974280, exp 12/2016; and b) 2525474, exp 05/2016

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0873-2016
Classification
Class I
Status
Terminated
Recall initiated
Oct 28, 2015
FDA report date
Jun 1, 2016
Quantity
159,000 prefilled injectors
Recall type
Voluntary: Firm initiated
Recalling firm
Sanofi-Aventis U.S. LLC

Original FDA data

Every field from FDA enforcement report D-0873-2016, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
72527
Address
55 Corporate Dr
Code information
a) 2144144, exp 10/2015; 2469674, exp 04/2016; 2506492, 2546978, 2546979, exp 05/2016; 2654817, 2654818, exp 06/2016; 2692143, 2692144, exp 07/2016; 2719838, exp 08/2016; 2824845, 2891021, 2857530, exp 09/2016; 2883631, 2883632, exp 10/2016; 2883633, 2945429, 3028243, exp 11/2016; 3037230, 2966680, 2974276, 2974280, exp 12/2016; and b) 2525474, exp 05/2016
Postal code
08807-1265
Report date
Jun 1, 2016
Product type
Drugs
Recall number
D-0873-2016
Classification
Class I
Recalling firm
Sanofi-Aventis U.S. LLC
Product quantity
159,000 prefilled injectors
Termination date
Jul 15, 2025
Reason for recall
Defective Delivery System; potential to have inaccurate dosage delivery
Voluntary / mandated
Voluntary: Firm initiated
Product description
Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.15 mg (a) 2 prefilled auto injectors + 1 trainer (NDC 0024-5831-02) and (b) 1 prefilled auto injector + 1 trainer (NDC 0024-5831-00), Rx Only, Manufactured for Sanofi-Aventis US, LLC Bridgewater, NJ 08807 A Sanofi Company
Distribution pattern
Nationwide
Recall initiation date
Oct 28, 2015
Initial firm notification
Press Release
Center classification date
May 25, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0873-2016, published Jun 1, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls